key: cord-0822270-bdxkrqxr authors: Bassoli, Cinzia; Oreni, Letizia; Ballone, Elisabetta; Foschi, Antonella; Perotti, Andrea; Mainini, Annalisa; Casalini, Giacomo; Galimberti, Laura; Meroni, Luca; Antinori, Spinello; Milazzo, Laura title: Role of serum albumin and proteinuria in patients with SARS‐CoV‐2 pneumonia date: 2020-12-26 journal: Int J Clin Pract DOI: 10.1111/ijcp.13946 sha: 90b652e077c4267b23672986431349d70443a51b doc_id: 822270 cord_uid: bdxkrqxr BACKGROUND: Hypoalbuminemia is frequently observed in patients with SARS‐CoV‐2 infection although its underlying mechanism and relationship with the clinical outcome still need to be clarified. METHODS: We retrospectively evaluated in patients with COVID‐19 hospitalised at the Fatebenefratelli‐Sacco Hospital in Milan, the prevalence of hypoalbuminemia, its association with the severity of COVID‐19, with the levels of C‐reactive protein, d‐dimer and interleukin‐6 and with clinical outcome over a follow‐up period of 30 days. Urinalysis was evaluated in a subgroup of patients. RESULTS: Serum albumin levels <30 g/L were found in 105/207 (50.7%) patients at hospital admission. Overall, the median albumin value was 29.5 g/L (IQR 25‐32.8). A negative association was found between albumin levels and severity of COVID‐19 (P < .0001) and death (P = .003). An inverse correlation was observed between albumin and both C‐reactive protein and D‐dimer at hospital admission (r = −.487 and r = −.479, respectively; P < .0001). Finally, a positive correlation was found between albumin levels and eGFR (r = .137; P = .049). Proteinuria was observed in 75% of patients with available data and it did not differ between patients with hypoalbuminemia and those with albumin ≥30 g/L (81% and 67%, respectively; P = .09). CONCLUSION: In patients with COVID‐19, hypoalbuminemia is common and observed in quite an early stage of pulmonary disease. It is strictly associated with inflammation markers and clinical outcome. The common finding of proteinuria, even in the absence of creatinine increase, indicates protein loss as a possible biomarker of local and systemic inflammation worthwhile to evaluate disease severity in COVID‐19. r = −.479, respectively; P < .0001). Finally, a positive correlation was found between albumin levels and eGFR (r = .137; P = .049). Proteinuria was observed in 75% of patients with available data and it did not differ between patients with hypoalbuminemia and those with albumin ≥30 g/L (81% and 67%, respectively; P = .09). In patients with COVID-19, hypoalbuminemia is common and observed in quite an early stage of pulmonary disease. It is strictly associated with inflammation markers and clinical outcome. The common finding of proteinuria, even in the absence of creatinine increase, indicates protein loss as a possible biomarker of local and systemic inflammation worthwhile to evaluate disease severity in COVID-19. The following data were retrieved from clinical charts at presentation: demographic data, concomitant diseases, severity of clinical presentation, fraction of inspired oxygen (FiO2), peripheral oxygen saturations, serum albumin levels, serum creatinine, levels of D-dimer and C-reactive protein (CRP), serum interleukin-6 (IL-6). Estimated glomerular filtration rate (eGFR) was calculated with the Modification of Diet in Renal Disease Study (MDRD) equation. 5 For those patients with available urinalysis, data on proteinuria, hematuria and urine leukocytes were collected. Serum albumin measurements were available for all the patients at three time-points within the first week of hospitalisation (admission, at day 3 and day 7 from admission) and were registered. The patients with a history of kidney diseases were excluded from this study. According to the Chinese Guidelines for the Diagnosis and Continuous variables were expressed as medians and interquartile range (IQR) and were compared using nonparametric tests (Wilcoxon's rank-sum or Kruskal-Wallis test). For the categorical variables, the χ 2 test was used, or Fisher's exact test when needed. Non-parametric analysis of the correlation between serum albumin levels and C-reactive protein, d-dimer, interleukin-6 and eGFR was assessed by Spearman's rank correlation coefficient r s . Two hundred and twenty-two consecutive patients with confirmed follow-up, while a persistent decrease occurred in patients eventually undergoing mechanical ventilation or death (medians of delta albumin 0 g/L and −9 g/L, respectively; P = .001) (Figure 4) . A complete urine examination was available for 136 of 207 patients. Proteinuria was observed in 102 (75%) patients, with a protein loss in the order of 50 mg/dL in 63% and of 100 mg/dL in 12%. Proteinuria did not significantly differ between patients with hypoalbuminemia and those with albumin ≥30 g/L (81% and 67%, respectively; P = .09). Twenty-five patients (18%) presented mild hematuria (between 0.5-1 mg/dL), while leukocyturia was present in 23 patients (17%) at the following extent: 25 leukocytes/μL in 11 (8%), 50-75 leukocytes/μL in 5 (3.6%), 250 leukocytes/μL in 4 (3%) and 500 leukocytes/μL in 3 (2.2%). and did not fulfill the diagnostic criteria of ARDS. 15 In a recent remarkable paper, high renal tropism of SARS-CoV-2 was demonstrated and it was suggested as a possible explanation of kidney injury even in patients with mild COVID-19 infection. 16 However, we confirmed here a strong association of hypoalbuminemia with respiratory impairment and disease severity as well as with inflammatory state. As far as urinalysis is concerned, a mild to moderate proteinuria was frequently observed in our cohort, independently from the level or serum albumin levels, thus reinforcing the hypothesis of a systemic endothelial leakage rather than a prevailing renal tubular damage. This is also supported by the observation of a low rate and mild extent of hematuria and leukocyturia. The main limitation of the study is represented by the lack of urinalysis in a number of patients and the unavailability of a 24-hour urine collection that could have allowed a more accurate definition of proteinuria. In addition, we could not evaluate an appropriate trend of serum albumin on a long follow-up period because of the retrospective nature of our study that did not allow a systematic approach to the timing of laboratory markers. In summary, hypoalbuminemia is common amongst COVID-19 patients and is strictly associated with inflammation markers and clinical outcome. The common finding of proteinuria, even in the absence of creatinine increase, indicates protein loss as a possible biomarker of local and systemic inflammation worthwhile to evaluate disease severity in COVID-19. The authors have declared no conflicts of interest for this article. Laura Milazzo https://orcid.org/0000-0003-3039-3039 Clinical and immunological features of severe and moderate coronavirus disease 2019 Clinical features of patients infected with 2019 novel coronavirus in Wuhan Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2 A tool to early predict severe corona virus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China Kidney disease is associated with in-hospital death of patients with COVID-19 Lung fluid movements in hypoxia Determining the aetiology of pulmonary oedema by the oedema fluid-to-plasma protein ratio The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches Experimental acute lung injury induces multi-organ epigenetic modifications in key angiogenic genes implicated in sepsis-associated endothelial dysfunction Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Acute respiratory distress syndrome: the Berlin Definition Multiorgan and renal tropism of SARS-CoV-2 Role of serum albumin and proteinuria in patients with SARS-CoV-2 pneumonia